Menu

Image of the Day: Watering Hole

A new study describes an unusual water harvesting method in plants.

Aug 8, 2018
Sukanya Charuchandra

ABOVE: MATT BIDDICK

A Pandanus forsteri root tip 
MATT BIDDICK 

Scientists have discovered an alternative water transport system in a screw pine tree (Pandanus forsteri) from Lord Howe Island, off the coast of Australia. Their findings were published August 1 in Proceedings of the Royal Society B. The tree’s aerial roots take years to reach soil, which prompts its use of a different mechanism of obtaining water; its leaves direct rainwater through channels to the tips of roots that store it in absorptive tissue.

M. Biddick et al., “An alternative water transport system in land plants,” Proceedings of the Royal Society B, doi:10.1098/rspb.2018.0995, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.